Products
entimo empowers sponsors, biotechs, and biometrics service providers of all sizes with software and services that simplify the complexity of clinical data workflows. Our regulatory-grade Statistical Computing Environment, entimICE FastTrack, enables teams to take in, transform, analyze, and submit clinical trial data with clarity, speed, and full compliance. Whether you're a global pharmaceutical company, a mid-sized biotech, or a CRO managing multi-sponsor studies, entimICE FastTrack adapts to your needs—fit-for-purpose, language-agnostic, and seamlessly integrated with industry-standard tools.
Global services
entimo assists pharmaceutical and biotech organizations with proven enterprise-grade software and domain-specific consulting expertise. Our expertise in statistical programming, technology services, R programming services, and consulting on businesses and processes has given clients advantages in how they approach clinical trials and regulatory submissions.
Innovation
We lead with innovation that’s grounded in compliance. From the first GxP-compliant SCE to cloud adoption and meaningful AI integration, we bring progress where it truly matters. Our open, future-ready platform respects existing systems while empowering researchers with the freedom to use tools and languages they trust.
Experience
With more than 20 years of expertise in life sciences informatics, we understand the complexity of clinical research like few others. Our solutions are shaped by real-world use across global sponsors and CROs—designed, delivered, and supported by experts who’ve seen it all and know what works.
Trust
Data, processes, procedures, partnerships—they all lead back to trust. Patients trust our sector to help improve their health. Every step toward new medications and new treatments depends on trust. For more than 20 years, entimo has kept our partners' trust and helped them meet regulatory standards: the place where trust meets proof.
Solutions for every company
Our platform is the choice of companies worldwide to streamline clinical trial data analysis and reporting. See how Entimo helped organizations to deliver better outcomes, faster and cost effectively.
entimo moves up in environmental rating
entimo’s 2025 Climate Change rating from CDP (formerly the Carbon Disclosure Project) has improved significantly compared to 2024, and now stands at a B level. This marks meaningful progress in our environmental transparency and climate action efforts. A rating at this level recognizes verified, evidence-based climate action and shows that entimo has moved from awareness into meaningful implementation.
Inside the 33rd BVMA Symposium
The 33rd BVMA Symposium in Munich brought together an extraordinary cross-section of Germany’s clinical research landscape including industry leaders, regulatory agencies, CROs, sponsors, NGOs, and government representatives. For entimo’s CEO, Marc Jantke, it was his first time stepping into what some attendees call a “class reunion.” As it turned out, the nickname was more accurate than he expected.
entimo Presents at PHUSE US Connect 2025
In March, entimo representatives joined industry colleagues at PHUSE US Connect in Orlando, Florida to drive conversations around innovations in SCEs and clinical data standards. Three from entimo delivered presentations, while the company sponsored the conference’s poster session.